| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.25 | 8e-06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.25 | 3e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |